{"id":107385,"date":"2026-06-05T11:46:25","date_gmt":"2026-06-05T06:16:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=107385"},"modified":"2026-06-05T11:46:27","modified_gmt":"2026-06-05T06:16:27","slug":"alivus-life-sciences-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/","title":{"rendered":"Alivus Life Sciences Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Alivus Life Sciences share price target 2026 is Rs 1,250, implying approximately 20 percent upside from the current market price of Rs 1,036 (NSE: ALIVUS). Q4 FY26 results announced May 30, 2026 are the key near-term re-rating trigger, with Pharmaceutical APIs and Life Sciences tailwinds and RBI rate cuts supporting the path to Rs 1,250.<\/em><\/p>\n<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\">Alivus Life Sciences<\/a> share price target 2026<\/strong> is Rs 1,250, based on analyst estimates and the FY27 earnings recovery thesis. Q4 FY26 results announced May 30, 2026 are the immediate trigger for re-rating Alivus Life Sciences (NSE: ALIVUS). This article covers the complete <strong>Alivus Life Sciences share price target<\/strong> analysis including sector tailwinds, key risks, and the bull and bear case scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Alivus_Life_Sciences_Company_Overview\" title=\"Alivus Life Sciences Company Overview\">Alivus Life Sciences Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Why_Is_the_Alivus_Life_Sciences_Share_Price_Target_Set_at_Rs_1250_for_2026\" title=\"Why Is the Alivus Life Sciences Share Price Target Set at Rs 1,250 for 2026\">Why Is the Alivus Life Sciences Share Price Target Set at Rs 1,250 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_APIs_and_Life_Sciences\" title=\"Structural Sector Tailwinds in Pharmaceutical APIs and Life Sciences\">Structural Sector Tailwinds in Pharmaceutical APIs and Life Sciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Union_Budget_2026-27_Policy_Support\" title=\"Union Budget 2026-27 Policy Support\">Union Budget 2026-27 Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Improving_FII_Flows_Post_the_April_2026_Tariff_Shock\" title=\"Improving FII Flows Post the April 2026 Tariff Shock\">Improving FII Flows Post the April 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Alivus_Life_Sciences_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Alivus Life Sciences Share Price Targets: Short Term, 12 Month, and Long Term\">Alivus Life Sciences Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Short_Term_Alivus_Life_Sciences_Share_Price_Target_3_to_6_Months\" title=\"Short Term Alivus Life Sciences Share Price Target: 3 to 6 Months\">Short Term Alivus Life Sciences Share Price Target: 3 to 6 Months<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#12-Month_Alivus_Life_Sciences_Share_Price_Target_2026\" title=\"12-Month Alivus Life Sciences Share Price Target 2026\">12-Month Alivus Life Sciences Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Long_Term_Alivus_Life_Sciences_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Alivus Life Sciences Share Price Target: FY27 to FY28\">Long Term Alivus Life Sciences Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Bull_Case_and_Bear_Case_for_the_Alivus_Life_Sciences_Share_Price_Target\" title=\"Bull Case and Bear Case for the Alivus Life Sciences Share Price Target\">Bull Case and Bear Case for the Alivus Life Sciences Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Bull_Case_Alivus_Life_Sciences_Share_Price_Target_Rs_1500\" title=\"Bull Case Alivus Life Sciences Share Price Target: Rs 1,500\">Bull Case Alivus Life Sciences Share Price Target: Rs 1,500<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Bear_Case_Alivus_Life_Sciences_Share_Price_Target_Rs_830\" title=\"Bear Case Alivus Life Sciences Share Price Target: Rs 830\">Bear Case Alivus Life Sciences Share Price Target: Rs 830<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Key_Risks_to_the_Alivus_Life_Sciences_Share_Price_Target_2026\" title=\"Key Risks to the Alivus Life Sciences Share Price Target 2026\">Key Risks to the Alivus Life Sciences Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#US_Tariff_and_Global_Macro_Risk\" title=\"US Tariff and Global Macro Risk\">US Tariff and Global Macro Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Valuation_and_Earnings_Miss_Risk\" title=\"Valuation and Earnings Miss Risk\">Valuation and Earnings Miss Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Competitive_Pressure_in_Pharmaceutical_APIs_and_Life_Sciences\" title=\"Competitive Pressure in Pharmaceutical APIs and Life Sciences\">Competitive Pressure in Pharmaceutical APIs and Life Sciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#FII_Selling_Pressure_and_Liquidity_Risk\" title=\"FII Selling Pressure and Liquidity Risk\">FII Selling Pressure and Liquidity Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#How_to_Invest_in_Alivus_Life_Sciences\" title=\"How to Invest in Alivus Life Sciences\">How to Invest in Alivus Life Sciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#FAQs_on_Alivus_Life_Sciences_Share_Price_Target_2026\" title=\"FAQs on Alivus Life Sciences Share Price Target 2026\">FAQs on Alivus Life Sciences Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#What_is_the_Alivus_Life_Sciences_share_price_target_for_2026\" title=\"What is the Alivus Life Sciences share price target for 2026?\">What is the Alivus Life Sciences share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#Is_Alivus_Life_Sciences_a_good_buy_at_the_current_price_of_Rs_1036\" title=\"Is Alivus Life Sciences a good buy at the current price of Rs 1,036?\">Is Alivus Life Sciences a good buy at the current price of Rs 1,036?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Alivus_Life_Sciences\" title=\"What is the 52 week high and low of Alivus Life Sciences?\">What is the 52 week high and low of Alivus Life Sciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#What_are_the_key_risks_to_the_Alivus_Life_Sciences_share_price_target_2026\" title=\"What are the key risks to the Alivus Life Sciences share price target 2026?\">What are the key risks to the Alivus Life Sciences share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#What_are_the_main_catalysts_for_the_Alivus_Life_Sciences_share_price_target\" title=\"What are the main catalysts for the Alivus Life Sciences share price target?\">What are the main catalysts for the Alivus Life Sciences share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-share-price-target-2026\/#What_is_the_Alivus_Life_Sciences_share_price_target_for_2027\" title=\"What is the Alivus Life Sciences share price target for 2027?\">What is the Alivus Life Sciences share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Alivus_Life_Sciences_Company_Overview\"><\/span><strong>Alivus Life Sciences Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alivus Life Sciences (NSE: ALIVUS) is a pharmaceutical API company producing bulk drugs and intermediates with DSIR-recognised R&amp;D and WHO-GMP manufacturing. At CMP Rs 1,036 against a 52 week range of Rs 735 to Rs 1,675, the stock trades at a meaningful discount to its 52 week high. Market capitalisation stands at Rs 1,554 crore with a trailing PE of sector-average.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>ALIVUS<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical APIs and Life Sciences<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 30, 2026)<\/td>\n<td>Rs 1,036<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,675<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 735<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 1,554 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>sector-average<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 1,250<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 1,500<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 830<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has now shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <strong style=\"color: #3b7fff;\">Top Stock Picks<\/strong> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=alivus-life-sciences\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Alivus_Life_Sciences_Share_Price_Target_Set_at_Rs_1250_for_2026\"><\/span><strong>Why Is the Alivus Life Sciences Share Price Target Set at Rs 1,250 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Alivus Life Sciences share price target 2026<\/strong> of Rs 1,250 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the recovery trajectory are the most direct catalyst for re-rating from CMP Rs 1,036 toward the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_APIs_and_Life_Sciences\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical APIs and Life Sciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical APIs and Life Sciences sector is expanding on the back of India&#8217;s strong domestic demand, PLI scheme support, and rising corporate investment. Alivus Life Sciences&#8217;s market position creates a structural growth runway supporting the <strong>Alivus Life Sciences share price target<\/strong> consensus of Rs 1,250 and the bull case of Rs 1,500.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle, which began in early 2026, reduces Alivus Life Sciences&#8217;s borrowing costs and stimulates demand across end markets. Lower interest costs improve EPS trajectory, directly supporting the <strong>Alivus Life Sciences share price target 2026<\/strong> of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Policy_Support\"><\/span><strong>Union Budget 2026-27 Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Alivus Life Sciences&#8217;s Pharmaceutical APIs and Life Sciences operations, improving the probability of achieving the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Improving_FII_Flows_Post_the_April_2026_Tariff_Shock\"><\/span><strong>Improving FII Flows Post the April 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering through FY27. At sector-average PE, Alivus Life Sciences is positioned as a beneficiary of institutional reallocation supporting the path to Rs 1,250.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alivus_Life_Sciences_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Alivus Life Sciences Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Alivus_Life_Sciences_Share_Price_Target_3_to_6_Months\"><\/span><strong>Short Term Alivus Life Sciences Share Price Target: 3 to 6 Months<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The near-term <strong>Alivus Life Sciences share price target<\/strong> is anchored to support near the 52 week low of Rs 735. A confirmed Q4 FY26 earnings recovery and positive FY27 guidance are the triggers for an initial 10 to 15 percent re-rating toward Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Alivus_Life_Sciences_Share_Price_Target_2026\"><\/span><strong>12-Month Alivus Life Sciences Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Alivus Life Sciences share price target 2026<\/strong> is Rs 1,250, implying approximately 20 percent upside from CMP Rs 1,036. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker ALIVUS.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Alivus_Life_Sciences_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Alivus Life Sciences Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For investors with a 2 to 3 year horizon, the long-term <strong>Alivus Life Sciences share price target<\/strong> is Rs 1,500 in the bull case, assuming full earnings delivery through FY27 to FY28 and sector re-rating in the Pharmaceutical APIs and Life Sciences space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_the_Alivus_Life_Sciences_Share_Price_Target\"><\/span><strong>Bull Case and Bear Case for the Alivus Life Sciences Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Alivus_Life_Sciences_Share_Price_Target_Rs_1500\"><\/span><strong>Bull Case Alivus Life Sciences Share Price Target: Rs 1,500<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case for the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,500 materialises when FY27 earnings beat analyst estimates, sector tailwinds accelerate, and FII flows return strongly to Indian equities. The stock re-rates toward higher peer multiples, making Rs 1,500 achievable within FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Alivus_Life_Sciences_Share_Price_Target_Rs_830\"><\/span><strong>Bear Case Alivus Life Sciences Share Price Target: Rs 830<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case sees the <strong>Alivus Life Sciences share price target<\/strong> testing Rs 830 if FY27 earnings disappoint and FII outflows persist. At Rs 830, the stock approaches the 52 week low support of Rs 735, requiring a full reassessment of the investment thesis.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1,500<\/td>\n<td>FY27 earnings beat, sector re-rating, strong FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 1,250<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 830<\/td>\n<td>FY27 earnings miss, guidance cut, sustained FII outflows<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Alivus_Life_Sciences_Share_Price_Target_2026\"><\/span><strong>Key Risks to the Alivus Life Sciences Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"US_Tariff_and_Global_Macro_Risk\"><\/span><strong>US Tariff and Global Macro Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 26 percent US reciprocal tariff announced April 2, 2026 triggered FII outflows across Indian equities. Prolonged trade tension or a global demand slowdown remains the most prominent macro risk to the <strong>Alivus Life Sciences share price target 2026<\/strong> of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Miss_Risk\"><\/span><strong>Valuation and Earnings Miss Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any FY27 earnings miss or guidance cut could trigger multiple compression, posing a direct risk to the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250. Monitoring quarterly results closely is essential for investors in Alivus Life Sciences.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Pressure_in_Pharmaceutical_APIs_and_Life_Sciences\"><\/span><strong>Competitive Pressure in Pharmaceutical APIs and Life Sciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition in the Pharmaceutical APIs and Life Sciences sector could compress Alivus Life Sciences&#8217;s pricing power and market share over the medium term, which must be factored into any assessment of the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Selling_Pressure_and_Liquidity_Risk\"><\/span><strong>FII Selling Pressure and Liquidity Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay re-rating toward the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250 regardless of company-level operational improvement through FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Alivus_Life_Sciences\"><\/span><strong>How to Invest in Alivus Life Sciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Begin by reviewing Alivus Life Sciences&#8217;s Q4 FY26 results, annual report, and FY27 guidance statements before forming a view on the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250. Focus on revenue growth trajectory, margin trends, and management commentary on sector headwinds and opportunities.<\/p>\n<p>Open a Demat and trading account with a SEBI registered stockbroker to buy Alivus Life Sciences (NSE: ALIVUS) with full regulatory protection. Ensure KYC is complete and understand the Pharmaceutical APIs and Life Sciences sector dynamics before executing any position.<\/p>\n<p>Plan your entry near the 52 week low support of Rs 735. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance would strengthen the entry case for the <strong>Alivus Life Sciences share price target<\/strong> of Rs 1,250. Set a disciplined stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in smaller-cap Pharmaceutical APIs and Life Sciences companies where liquidity and volatility can amplify losses.<\/p>\n<p>Always consult a SEBI registered financial advisor before investing based on any <strong>Alivus Life Sciences share price target<\/strong> estimate. A registered advisor personalises recommendations based on your risk profile and financial goals. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Alivus Life Sciences&#8217;s live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Alivus_Life_Sciences_Share_Price_Target_2026\"><\/span><strong>FAQs on Alivus Life Sciences Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Alivus_Life_Sciences_share_price_target_for_2026\"><\/span><strong>What is the Alivus Life Sciences share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Alivus Life Sciences share price target 2026 is Rs 1,250, implying approximately 20 percent upside from CMP Rs 1,036. The bull case target is Rs 1,500 and the bear case target is Rs 830.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Alivus_Life_Sciences_a_good_buy_at_the_current_price_of_Rs_1036\"><\/span><strong>Is Alivus Life Sciences a good buy at the current price of Rs 1,036?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 1,036, Alivus Life Sciences offers potential upside to the share price target of Rs 1,250 if FY27 earnings recover as projected. Consult a SEBI registered financial advisor before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Alivus_Life_Sciences\"><\/span><strong>What is the 52 week high and low of Alivus Life Sciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Alivus Life Sciences is Rs 1,675 and the 52 week low is Rs 735. At CMP Rs 1,036, the stock offers upside potential toward the 12-month share price target of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Alivus_Life_Sciences_share_price_target_2026\"><\/span><strong>What are the key risks to the Alivus Life Sciences share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Alivus Life Sciences share price target of Rs 1,250 include an FY27 earnings miss, US tariff-driven FII outflows, competitive pressure in Pharmaceutical APIs and Life Sciences, and broader market volatility.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_catalysts_for_the_Alivus_Life_Sciences_share_price_target\"><\/span><strong>What are the main catalysts for the Alivus Life Sciences share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Primary catalysts include FY27 PAT recovery, structural tailwinds in Pharmaceutical APIs and Life Sciences, RBI rate cut support, Union Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities through FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Alivus_Life_Sciences_share_price_target_for_2027\"><\/span><strong>What is the Alivus Life Sciences share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Alivus Life Sciences share price target for FY27 to FY28 is Rs 1,500 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Alivus Life Sciences share price target 2026 is Rs 1,250, ~20% upside from CMP Rs 1,036. Bull case Rs 1,500, bear case Rs 830. May 2026.<\/p>\n","protected":false},"author":28,"featured_media":108017,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-107385","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1780640189:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Alivus Life Sciences Share Price Target 2026: Rs 1,250 Analyst Forecast"],"rank_math_description":["The Alivus Life Sciences share price target 2026 is Rs 1,250, ~20% upside from CMP Rs 1,036. Bull case Rs 1,500, bear case Rs 830. May 2026."],"rank_math_focus_keyword":["Alivus Life Sciences Share Price Target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_date":["2026-06-04"],"_thumbnail_id":["108017"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["15678"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Alivus-Life-Sciences-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/107385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=107385"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/107385\/revisions"}],"predecessor-version":[{"id":108018,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/107385\/revisions\/108018"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/108017"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=107385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=107385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=107385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}